GlassScriptPhysician profile
Joseph M Scherba
NPI 1225406259
$5,698.97
in general payments reported to CMS, 2019-2025
38 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 84% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,154 · 2022: $1,024 · 2023: $891 · 2024: $1,396 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,521.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $735.85 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $712.07 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $511.19 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $472.55 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Abbvie INC. | $435.26 | 2021-2025 | |
| Amgen INC. | $425.33 | 2021-2025 | Repatha, Evenity, Repatha |
| Exact Sciences Corporation | $376.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $285.83 | 2021-2025 | |
| Glaxosmithkline, LLC. | $209.18 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $185.29 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $115.25 | 2021-2022 | |
| Baxter Healthcare | $113.55 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.28 | 2023-2025 | Xifaxan |
| Amarin Pharma, INC. | $100.04 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $99.11 | 2021-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Scherba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.